| Original language | English |
|---|---|
| Article number | 603 |
| Journal | Frontiers in Immunology |
| Volume | 9 |
| Issue number | APR |
| DOIs | |
| Publication status | Published (VoR) - 12 Apr 2018 |
Funding
We acknowledge support from the IRIDIS 4 High Performance Computing Facility and associated support services at the University of Southampton, the Collaboratory of AIDS Researchers for Eradication (CARE), the Bioinformatics Core at the University of Southampton, and the Genomics and Sequencing Core at the UCSD Center for AIDS Research. This work was performed with the support of the UCSD Center for AIDS Research from the National Institutes of Health (NIH) to DR (P30 AI36214); the U.S. Department of Veterans Affairs grant (K2BX002731) to NBB; the James B. Pendleton Charitable Trust; as well as other NIH grants to DR (the CARE Martin Delaney Collaboratory U19 AI096113) and to CWo (AI104282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Keywords
- Histone deacetylase inhibitor
- Human endogenous retroviruses
- Long terminal repeat
- Primary CD4 T cells
- Total RNA-Seq